Marye Gleva

Medicine & Life Sciences

1. Implantable Defibrillators 100%
2. Defibrillators 71%
3. Cardiac Resynchronization Therapy 39%
4. Shock 34%
5. Tachycardia 30%
6. Equipment and Supplies 29%
7. Lead 26%
8. Cardiomyopathies 22%
9. Registries 22%
10. Ventricular Tachycardia 20%
11. Ventricular Fibrillation 19%
12. Atrial Fibrillation 19%
13. Primary Prevention 19%
14. Maze Procedure 17%
15. Anti-Arrhythmia Agents 16%
16. Electrocardiography 15%
17. Heart Diseases 15%
18. Cardiac Arrhythmias 14%
19. Lasers 13%
20. Heart Failure 12%
21. Infections 12%
22. Heart 12%
23. Safety 12%
24. Left Ventricular Function 10%
25. Mortality 10%
26. Catheter Ablation 9%
27. Recurrence 8%
28. Survival 8%
29. Atrioventricular Nodal Reentry Tachycardia 8%
30. SARS Virus 8%
31. Sudden Cardiac Death 7%
32. Confidence Intervals 7%
33. Magnetic Resonance Imaging 7%
34. Electrodes 7%
35. Stroke Volume 6%
36. Atrial Premature Complexes 6%
37. Radiofrequency Ablation 6%
38. Ventricular Remodeling 6%
39. Sudden Death 6%
40. Hypertrophic Cardiomyopathy 6%
41. Ambulatory Electrocardiography 6%
42. Syncope 6%
43. Therapeutics 5%
44. Chronic Renal Insufficiency 5%
45. Clinical Protocols 5%
46. Anti-Bacterial Agents 5%